Aptamers: Promising Reagents in Biomedicine Application
Authors:
- 15 March 2024
- journal article
- review article
- Published by Wiley in Advanced Biology
- Vol. 8 (6) , e2300584
Abstract
Nucleic acid aptamers, often termed “chemical antibodies,” are short, single‐stranded DNA or RNA molecules, which are selected by SELEX. In addition to their high specificity and affinity comparable to traditional antibodies, aptamers have numerous unique advantages such as wider identification of targets, none or low batch‐to‐batch variations, versatile chemical modifications, rapid mass production, and lack of immunogenicity. These characteristics make aptamers a promising recognition probe for scientific research or even clinical application. Aptamer‐functionalized nanomaterials are now emerged as a promising drug delivery system for various diseases with decreased side‐effects and improved efficacy. In this review, the technological strategies for generating high‐affinity and biostable aptamers are introduced. Moreover, the development of aptamers for their application in biomedicine including aptamer‐based biosensors, aptamer–drug conjugates and aptamer functionalized nanomaterials is comprehensively summarized.Keywords
Funding Information
- National Natural Science Foundation of China (82073216)
This publication has 116 references indexed in Scilit:
- Biomimetic Nanoerythrosome‐Coated Aptamer–DNA Tetrahedron/Maytansine Conjugates: pH‐Responsive and Targeted Cytotoxicity for HER2‐Positive Breast CancerAdvanced Materials, 2022
- Aptamer‐PROTAC Conjugates (APCs) for Tumor‐Specific Targeting in Breast CancerAngewandte Chemie International Edition, 2021
- Enhancing anti‐PD‐1 Immunotherapy by Nanomicelles Self‐Assembled from Multivalent Aptamer Drug ConjugatesAngewandte Chemie International Edition, 2021
- Multiparameter Particle Display (MPPD): A Quantitative Screening Method for the Discovery of Highly Specific AptamersAngewandte Chemie International Edition, 2016
- An In Vitro Selection Protocol for Threose Nucleic Acid (TNA) Using DNA DisplayCurrent Protocols in Nucleic Acid Chemistry, 2014
- Particle Display: A Quantitative Screening Method for Generating High‐Affinity AptamersAngewandte Chemie International Edition, 2014
- A Hybrid DNA Aptamer–Dendrimer Nanomaterial for Targeted Cell LabelingMacromolecular Bioscience, 2009
- The Chemical Biology of AptamersAngewandte Chemie International Edition, 2009
- An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery PlatformAngewandte Chemie International Edition, 2006
- Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†Hepatology, 2005